RAPT Therapeutics Gains 29% In 5 Days, FLX475 Phase 2 Data Due In Q2

Shares of RAPT Therapeutics Inc. (RAPT) have gained nearly 29 percent over the last five trading days as the Company gears up for some near-term clinical milestones.

from RTT - Biotech https://ift.tt/30o4RQm
via IFTTT